894 related articles for article (PubMed ID: 36389725)
1. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
2. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.
Yang B; Wang Y; Liu T; Zhang M; Luo T
Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
5. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics-based analysis of programmed cell death pathway and key prognostic genes in gastric cancer: Implications for the development of therapeutics.
Huang L; Xiong W; Cheng L; Li H
J Gene Med; 2024 Jan; 26(1):e3590. PubMed ID: 37670467
[TBL] [Abstract][Full Text] [Related]
8. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
[No Abstract] [Full Text] [Related]
9. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma.
Wei K; Zhang X; Yang D
PeerJ; 2023; 11():e16643. PubMed ID: 38130918
[TBL] [Abstract][Full Text] [Related]
10. Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes.
Li Z; Yang W; Liu D; Ye W; Du G; Li X
Sci Rep; 2022 Aug; 12(1):13290. PubMed ID: 35918354
[TBL] [Abstract][Full Text] [Related]
11. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer.
Xin D; Man Y; Yang Y; Wang F
Front Genet; 2022; 13():953997. PubMed ID: 36092932
[No Abstract] [Full Text] [Related]
13. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
14. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.
Sun M; Ji X; Xie M; Chen X; Zhang B; Luo X; Feng Y; Liu D; Wang Y; Li Y; Liu B; Xia L; Huang W
Front Immunol; 2022; 13():999084. PubMed ID: 36544770
[TBL] [Abstract][Full Text] [Related]
15. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer.
Pu S; Zhou Y; Xie P; Gao X; Liu Y; Ren Y; He J; Hao N
Front Immunol; 2022; 13():964118. PubMed ID: 36059470
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
17. A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.
Chen J; Wang H; Zhou L; Liu Z; Chen H; Tan X
Cancer Med; 2022 Dec; 11(24):5079-5096. PubMed ID: 35560794
[TBL] [Abstract][Full Text] [Related]
18. GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.
Xu W; Jiang T; Shen K; Zhao D; Zhang M; Zhu W; Liu Y; Xu C
Front Endocrinol (Lausanne); 2023; 14():1224832. PubMed ID: 37608794
[TBL] [Abstract][Full Text] [Related]
19. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
Xu L; Gao X; Xing J; Guo Z
Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
[TBL] [Abstract][Full Text] [Related]
20. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis.
Huo J; Xie W; Fan X; Sun P
Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
